The ESMO Deep Dive - Breast Cancers Webinar Series recordings and slides are available to all ESMO Members.
ESMO Deep Dive: Breast Cancer – Early Stage Triple-negative Breast Cancer: Hot Topics and Future Trends 2024
Chairs’ welcome
It is with great pleasure that I invite you to participate in the ESMO Deep Dive Breast Cancer Webinar on the topic of early stage triple-negative breast cancer: hot topics and future trends.
This webinar is developed with the aim to provide a second, deeper layer of educational experience in emerging data related to: molecular biology and classification, translational research and biomarkers for precision medicine, and unknowns, hypotheses, and ongoing research in areas of controversy or unmet need for optimal management of patients.
We will begin with a brief welcome and introduction, then a lecture on the de-escalation strategies and guiding principles from emerging data. This will be followed by a talk on immunotherapy, and lastly, we will discuss the best ways to handle suboptimal responders. The lectures will be followed by a live discussion with the speakers’ panel.
This programme is designed to provide an overview of the latest understanding of molecular biology and the impact of targeting different pathways in the management of patients with breast cancers, offer expert opinion exchange and provide some important considerations in this field. I strongly encourage and invite you to register and join us all in this new ESMO activity.
Prof. Peter Schmid
Barts Cancer Institute, London, UK
Speakers
Programme
Time |
Title |
Speaker |
|---|---|---|
5 min |
Welcome and introduction |
Peter Schmid |
25 min |
De-escalation strategies and guiding principles from emerging data |
Oleg Gluz |
25 min |
Immunotherapy: have we answered all questions? |
Peter Schmid |
25 min |
What shall we do with suboptimal responders? |
Aditya Bardia |
15 min |
LIVE Discussion and Q&A |
All |
Live viewers of the webinar will be awarded a certificate of attendance and 2 ESMO-MORA category 1 points
Learning objectives:
- To acquire a deeper understanding of the clinical course of malignant disease of breast cancer.
- To understand biological hypotheses on classification and risk stratification, ongoing/required research in therapeutics and knowledge of use of omics technologies for biomarker-enabled precision medicine for breast cancer.
- To develop skills and abilities for critical analysis, interpretation of research data and therapeutic strategies.
- To become better equipped for informed, innovative thinking and engagement in ongoing or new research projects.
Supported by
Meeting resources
The ESMO Deep Dive - Breast Cancers Webinar Series recordings and slides are available to all ESMO Members.